Current Requirements for Assessment of Elemental Impurities (Heavy Metals) in Medicines


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

One element of ensuring the quality and safety of medicines consists of normalizing and controlling elemental impurities (heavy metals). The sources and causes of the presence of elemental impurities (heavy metals) in medicines are discussed. Changes in approaches to assessment of elemental impurities in medicines in the State Pharmacopeia and leading non-Russian pharmacopeias are discussed. A risk-oriented approach to assessing elemental impurities used in international practice is presented.

作者简介

E. Kovaleva

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. Belanova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. Panova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. Zakharchenko

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##